MIC (Lipo C with B12)

Variable multi-ingredient MIC/Lipo-C formulation · lot-specific B12-containing research mixture

Component-wise specification; confirm on released-lot COA · target, verify batch COACAS 63-68-3RUO

Research statusVariable, non-standardized mixture; no direct controlled clinical evidence identified for a single defined MIC/Lipo-C plus B12 formulation.

Supplied formMulti-ingredient aqueous small-molecule formulation (non-peptide; no single molecular identity)

Lead timeConfirmed with quote

MIC (Lipo C with B12) — Lot-specific aqueous solution; color may vary with the cobalamin form — confirm clarity, color and particulate limits on the released-lot COA

Representative packaging image · verify the ordered lot

Decision summary

Key benefits

Claims of fat mobilization, weight loss, energy, liver support or synergy with GLP-1 medicines are not supported by a direct trial of a defined MIC/Lipo-C plus B12 formulation
Choline, methionine, inositol, vitamin B12 and L-carnitine have established biochemical roles or indication-specific evidence, but those facts cannot be added together to prove a compounded mixture's clinical benefit.

Published research context is presented for literature orientation only. It is not a dosing, treatment or human-use instruction.

Qualification data

Specifications to confirm against the released lot

CAS: 63-68-3
Formula: Not applicable — mixture or multi-component material
Molecular weight: Component-specific; no single molecular weight
Appearance: Lot-specific aqueous solution; color may vary with the cobalamin form — confirm clarity, color and particulate limits on the released-lot COA
Purity: Component-wise specification; confirm on released-lot COA · target, verify batch COA
Storage: Follow the exact product label, pharmacy or manufacturer documentation and lot-specific stability data. Cyanocobalamin is light-sensitive, while pH, preservative, container, concentration and added ingredients can change stability. Room-temperature and refrigerated instructions are not interchangeable across formulations, and a beyond-use date must not be inferred from the product name.
MOQ: On request
Lead time: Confirmed with quote

Qualification matrix

Identity, purity and content are separate release questions.

Identity

Confirm the stated molecule and supplied form. Start with the matching batch COA; request sequence-level evidence only when the buyer's written procedure requires it and availability or a separate scope has been agreed.

Purity

Review RP-HPLC method conditions, wavelength, integration and related-peak handling. A percentage without the method is not enough.

Content

Net peptide content is not the same as gross lyophilized powder weight. Ask which assay supports the stated amount and whether water/counter-ion is addressed.

Stability

Define long-term storage and transit exposure separately. Cold-chain can be quoted when the buyer’s risk assessment requires it and adds cost.

Research context

What researchers study about MIC (Lipo C with B12)

MIC and Lipo-C are non-standardized market labels rather than one pharmaceutical composition. MIC commonly refers to methionine, inositol and choline, often with vitamin B12; Lipo-C may additionally or alternatively refer to L-carnitine-containing formulations. Concentrations, vitamin B12 form, excipients, preservatives and added prescription ingredients can differ materially. A targeted literature review did not identify a peer-reviewed clinical trial or systematic review evaluating one defined MIC/Lipo-C plus B12 injection for weight loss or general wellness. Evidence about individual nutrients, deficiency treatment or PCOS cannot establish efficacy or safety of the combination. Compounded drugs are not FDA-approved before marketing, and FDA does not pre-verify their safety, effectiveness or manufacturing quality in the same way as approved products; federal and state compounding requirements still apply. This catalogue material is research use only and not for human administration.

No indication is established for the combination itself
Component-level literature addresses nutritional reference intakes, vitamin B12 deficiency and specific inositol questions such as PCOS; it does not prove weight loss, lipolysis, wellness benefit or additive efficacy of a MIC/Lipo-C injection.

Mechanism context

The question the literature is testing

Each ingredient participates in different biochemical pathways, but a plausible component mechanism is not evidence that the injected combination causes weight loss. Choline supports phospholipid and one-carbon metabolism; methionine is an essential amino acid and methyl-group source; inositol participates in cellular signaling; vitamin B12 supports cofactor-dependent metabolism; and L-carnitine, when present, transports long-chain fatty acids into mitochondria. Formula-specific exposure, deficiency status and clinical context determine relevance.

Evidence map

Research routes and exposure context

Evidence tierHuman clinical research

Research areaOther research materials

Routes reported in sources

SubcutaneousIntramuscular

Dose / exposure contextProtocol-specific; verify the cited primary source

Routes and exposure contexts summarize cited studies or approved finished-product labels. They are not instructions for administering this RUO material; no customer dose is provided.

Evidence boundaries

Compatibility, limitations and decision context

Safety depends on the exact formulation, concentration, sterility assurance, route and recipient
No direct trial established the safety of a standardized MIC/Lipo-C plus B12 injection because no standardized product exists
Compounded drugs are not FDA-approved and do not undergo the same premarket review as approved medicines; this does not mean compounding is wholly unregulated
Ingredient-level upper intake limits and adverse effects are not a substitute for injectable-combination safety data
Undisclosed semaglutide, tirzepatide, phentermine or other active drugs would be a critical misbranding and safety concern
This catalogue material must not be administered to humans.

Interactions reported in the literature

A universal interaction profile cannot be assigned without a complete quantitative formula and patient context
Added prescription ingredients, vitamin B12 form, methionine load, choline exposure and L-carnitine presence can materially change risks
Evidence or warnings for one component do not automatically describe the combination, and no controlled interaction study of MIC/Lipo-C with GLP-1 medicines was located.

Literature context is not a supplier release result or human-use instruction. Follow your institution's approved laboratory risk assessment.

Factory batch documentation

MIC (Lipo C with B12) factory batch COAs

No factory batch COA is published for this product yet. Ask sales for the latest available document.

Representative records, refreshed periodically

Published COAs show representative factory batches and may not be the latest available. For a current quote or shipment, our sales team can confirm the applicable lot and provide its COA.

Independent testing, arranged on request

Third-party reports are not routinely published. If independent verification is required, we can agree the laboratory, method, acceptance criteria and remedy before testing. If the agreed specification is not met, an appropriate resolution—including a refund where applicable—can be discussed under the agreed terms. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.

Help reviewing your COA

Need help reading a factory COA or third-party report? Our sales team can clarify test items, specifications and how the results relate to the lot under discussion.

Ask for the current packet, not a generic certificate

Qualification must begin with a complete quantitative formula: chemical form of every ingredient, concentration per millilitre, excipients, preservative, pH, container, lot and beyond-use or expiry basis
Require identity and assay methods appropriate to each component, degradant and impurity controls, particulate testing, sterility and bacterial-endotoxin results for parenteral claims, container-closure integrity where applicable, and validated stability under the labelled conditions
A generic MIC, Lipo-B or Lipo-C label, a single CAS number, clear appearance or pharmacy-accreditation claim cannot replace batch evidence
Confirm that no undeclared prescription active is present.

Released-batch COARP-HPLC result and method contextIdentity result appropriate to the moleculeWater / counter-ion context where relevantSDS and handling statementAdditional testing scoped on request

Available fills

Quote the fill and pack configuration you need

Reference SKUFillBase pack

MICB12-10MG10 mg10 vials

Handling

Storage in the lab and temperature during transit are different decisions

Follow the exact product label, pharmacy or manufacturer documentation and lot-specific stability data. Cyanocobalamin is light-sensitive, while pH, preservative, container, concentration and added ingredients can change stability. Room-temperature and refrigerated instructions are not interchangeable across formulations, and a beyond-use date must not be inferred from the product name.

State destination, season, acceptable transit exposure and whether your protocol requires insulated or cold-chain service. Additional temperature-control cost is quoted explicitly.

Buyer FAQ

Terms to settle before the purchase order

Can a buyer arrange third-party testing?+

Yes. Testing must be performed by a mutually accepted, established specialist laboratory. Fee allocation, specification, sampling, method and acceptance rule must be agreed before testing; if an agreed independent result shows nonconformance, the remedy follows the signed order terms. Unless otherwise agreed in writing, the buyer pays the cost of this optional testing.

Does HPLC purity prove peptide content?+

No. Chromatographic purity describes the relative peak profile under a stated method. Identity, water, counter-ion, residual solvents and assay/content may require separate methods.

Is cold-chain shipping always required?+

Not always. Heat can accelerate degradation, especially during summer and long transit. Cold-chain reduces exposure but raises cost. State the destination and stability risk so the right service can be quoted.

How are payment terms handled?+

Available methods and milestones depend on order value, destination and project type. The pro forma invoice should state currency, bank details, fees, payment milestones and the release condition.

Why must the testing laboratory understand peptide chemistry?+

Free-base and salt forms, hydrophilic and hydrophobic sequences, aggregation and adsorption can change sample preparation and method suitability. Use a laboratory experienced with the molecule class.

External qualification references

WHO good storage and distribution practices IATA Temperature Control Regulations ISO/IEC 17025 laboratory competence 21 CFR 211.84 component testing and supplier COA controls

These are buyer-qualification references, not claims that this RUO material is regulated, certified or released under those frameworks. Applicability depends on the buyer's workflow and jurisdiction.

Selected sources

Literature behind the research context

No direct peer-reviewed efficacy or safety study of a standardized MIC/Lipo-C plus B12 injection was located. The Institute of Medicine choline chapter and NIH vitamin B12 fact sheet provide component background. The Cochrane review compares oral and intramuscular vitamin B12 for deficiency, not weight loss or this mixture. The 2024 inositol systematic review addresses PCOS and reports limited or uncertain evidence for several outcomes. The 2005 Cochrane version is superseded by the updated review and should not be counted as independent evidence. A telehealth article is an industry perspective, not a primary clinical source.

01
Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (Choline chapter)
National Academies Press (US) / NCBI Bookshelf · 1998 · authoritative nutrition science reference (Institute of Medicine dietary reference report)
Open source
02
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency
Cochrane Database of Systematic Reviews · 2018 · Cochrane systematic review
Open source
03
Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
The Journal of Clinical Endocrinology & Metabolism · 2024 · systematic review and meta-analysis (used to inform international clinical guidelines)
Open source
04
Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency (2005 original review, superseded by 2018 pub3)
Cochrane Database of Systematic Reviews · 2005 · Cochrane systematic review (original version, historical reference only)
Open source
05
Vitamin B12: Fact Sheet for Health Professionals
NIH Office of Dietary Supplements · 2025 · government health-professional fact sheet (NIH)
Open source
06
Lipo C and Tirzepatide: Safety and Clinical Evidence Review
Fella Health (medical weight-loss telehealth company) · 2026 · industry/company consumer-health guide (medical weight-loss telehealth provider)
Open source

Product FAQ

Questions buyers ask about MIC (Lipo C with B12)

Does MIC or Lipo-C identify one standardized formula?+

No. MIC commonly means methionine, inositol and choline, often with a vitamin B12 form; Lipo-C may also refer to L-carnitine-containing or otherwise expanded mixtures. The 10 mg presentation label does not disclose the identity or amount of each component. Before ordering, obtain the complete quantitative formula per millilitre, chemical form of every component, fill volume, excipients, preservative, pH and container.

Does component-level evidence prove that a MIC/Lipo-C plus B12 mixture causes weight loss or increases energy?+

No direct peer-reviewed trial of one standardized MIC/Lipo-C plus B12 formulation was identified. Nutrient physiology, treatment of a documented deficiency, oral inositol evidence in PCOS or L-carnitine studies cannot be added together to prove efficacy, safety or synergy for a different injected mixture. NIH also notes that vitamin B12 does not increase energy in people who already obtain enough. Treat weight-loss, wellness and GLP-1-add-on claims as unverified unless supported by formula-specific controlled evidence.

What batch evidence is needed for a multi-ingredient aqueous research mixture?+

Require identity and quantitative assay for every declared component, suitable multi-analyte method validation, degradant and impurity controls, pH, fill volume, excipient and preservative disclosure, particulates, container information and stability under the labelled conditions. If a parenteral-quality claim is made, sterility, bacterial endotoxins and container-closure integrity require separate method-qualified evidence. A generic market name, clear appearance, single CAS or total milligram label is not a batch COA.

MIC (Lipo C with B12)

Key benefits

Specifications to confirm against the released lot

Identity, purity and content are separate release questions.

What researchers study about MIC (Lipo C with B12)

The question the literature is testing

Research routes and exposure context

Compatibility, limitations and decision context

Interactions reported in the literature

MIC (Lipo C with B12) factory batch COAs

Ask for the current packet, not a generic certificate

Quote the fill and pack configuration you need

Storage in the lab and temperature during transit are different decisions

Terms to settle before the purchase order

Literature behind the research context

Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (Choline chapter)

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency

Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency (2005 original review, superseded by 2018 pub3)

Vitamin B12: Fact Sheet for Health Professionals

Lipo C and Tirzepatide: Safety and Clinical Evidence Review

Questions buyers ask about MIC (Lipo C with B12)

Compare adjacent molecules and documentation needs.

L-Carnitine liquid

Vitamin B12

Lemon Bottle

Lipo-C